Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug delivery
MedTech
BD plans to surf GLP-1 wave to a $1B drug delivery biz by 2030
“We believe that no other company in medtech is better positioned than BD to capitalize on this trend,” CEO Tom Polen said on an earnings call.
Conor Hale
Aug 1, 2024 11:30am
A brain parasite has been turned into drug delivery system
Jul 29, 2024 2:55pm
Tiba wins BARDA contract to develop RNAi flu therapeutics
Jul 11, 2024 3:35pm
The most valuable R&D projects? You guessed it: obesity
Jul 11, 2024 5:00am
Regeneron signs Mammoth gene editing deal worth $100M upfront
Apr 25, 2024 8:49am
Daily aspirin use may limit spread of colorectal tumor cells
Apr 23, 2024 3:50am